167 related articles for article (PubMed ID: 17690691)
1. Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Sato T; Kinukawa N; Morimoto A; Isoyama K; Kosaka Y; Oda T; Oda M; Hayashi Y; Eguchi M; Horibe K; Nakahata T; Mizutani S; Ishii E
Leukemia; 2007 Nov; 21(11):2258-63. PubMed ID: 17690691
[TBL] [Abstract][Full Text] [Related]
2. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
3. Risk-directed treatment of infant acute lymphoblastic leukaemia based on early assessment of MLL gene status: results of the Japan Infant Leukaemia Study (MLL96).
Isoyama K; Eguchi M; Hibi S; Kinukawa N; Ohkawa H; Kawasaki H; Kosaka Y; Oda T; Oda M; Okamura T; Nishimura S; Hayashi Y; Mori T; Imaizumi M; Mizutani S; Tsukimoto I; Kamada N; Ishii E
Br J Haematol; 2002 Sep; 118(4):999-1010. PubMed ID: 12199778
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.
Yeoh AE; Ariffin H; Chai EL; Kwok CS; Chan YH; Ponnudurai K; Campana D; Tan PL; Chan MY; Kham SK; Chong LA; Tan AM; Lin HP; Quah TC
J Clin Oncol; 2012 Jul; 30(19):2384-92. PubMed ID: 22614971
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
[TBL] [Abstract][Full Text] [Related]
6. Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia.
Koh K; Tomizawa D; Moriya Saito A; Watanabe T; Miyamura T; Hirayama M; Takahashi Y; Ogawa A; Kato K; Sugita K; Sato T; Deguchi T; Hayashi Y; Takita J; Takeshita Y; Tsurusawa M; Horibe K; Mizutani S; Ishii E
Leukemia; 2015 Feb; 29(2):290-6. PubMed ID: 24888273
[TBL] [Abstract][Full Text] [Related]
7. Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.
Tomizawa D; Kato M; Takahashi H; Fujimura J; Inukai T; Fukushima T; Kiyokawa N; Koh K; Manabe A; Ohara A
Int J Hematol; 2015 Nov; 102(5):602-10. PubMed ID: 26410102
[TBL] [Abstract][Full Text] [Related]
8. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y; Koh K; Kinukawa N; Wakazono Y; Isoyama K; Oda T; Hayashi Y; Ohta S; Moritake H; Oda M; Nagatoshi Y; Kigasawa H; Ishida Y; Ohara A; Hanada R; Sako M; Sato T; Mizutani S; Horibe K; Ishii E
Blood; 2004 Dec; 104(12):3527-34. PubMed ID: 15297313
[TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
10. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study.
Mann G; Attarbaschi A; Schrappe M; De Lorenzo P; Peters C; Hann I; De Rossi G; Felice M; Lausen B; Leblanc T; Szczepanski T; Ferster A; Janka-Schaub G; Rubnitz J; Silverman LB; Stary J; Campbell M; Li CK; Suppiah R; Biondi A; Vora A; Valsecchi MG; Pieters R;
Blood; 2010 Oct; 116(15):2644-50. PubMed ID: 20592248
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].
Cabrera ME; Campbell M; Quintana J; Undurraga MS; Ford AA; Greaves MF
Rev Med Chil; 2001 Jun; 129(6):634-42. PubMed ID: 11510203
[TBL] [Abstract][Full Text] [Related]
12. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig WD; Janka-Schaub G; Schrappe M; Harbott J
Leukemia; 2002 Sep; 16(9):1685-90. PubMed ID: 12200682
[TBL] [Abstract][Full Text] [Related]
13. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
Chowdhury T; Brady HJ
Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
[TBL] [Abstract][Full Text] [Related]
14. [Risk-adapted therapeutic stratification of infantile acute lymphocytic leukemia based on MLL-gene rearrangement].
Tomizawa D
Rinsho Ketsueki; 2008 Mar; 49(3):171-81. PubMed ID: 18421958
[No Abstract] [Full Text] [Related]
15. A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial.
Tomizawa D; Miyamura T; Imamura T; Watanabe T; Moriya Saito A; Ogawa A; Takahashi Y; Hirayama M; Taki T; Deguchi T; Hori T; Sanada M; Ohmori S; Haba M; Iguchi A; Arakawa Y; Koga Y; Manabe A; Horibe K; Ishii E; Koh K
Blood; 2020 Oct; 136(16):1813-1823. PubMed ID: 32845001
[TBL] [Abstract][Full Text] [Related]
16. Treatment of infant acute lymphoblastic leukemia in Japan. Childhood Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
Nishimura S; Kobayashi M; Ueda K; Ishii E; Okamura J; Kawaha K; Akiyama Y; Imashuku S; Horibe K; Matsuyama T; Shibuya A; Imaizumi M; Tsukimoto I; Nagao T
Int J Hematol; 1999 Jun; 69(4):244-52. PubMed ID: 10407581
[TBL] [Abstract][Full Text] [Related]
17. Favorable outcome for infant acute lymphoblastic leukemia after hematopoietic stem cell transplantation.
Jacobsohn DA; Hewlett B; Morgan E; Tse W; Duerst RE; Kletzel M
Biol Blood Marrow Transplant; 2005 Dec; 11(12):999-1005. PubMed ID: 16338622
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
Dreyer ZE; Dinndorf PA; Camitta B; Sather H; La MK; Devidas M; Hilden JM; Heerema NA; Sanders JE; McGlennen R; Willman CL; Carroll AJ; Behm F; Smith FO; Woods WG; Godder K; Reaman GH
J Clin Oncol; 2011 Jan; 29(2):214-22. PubMed ID: 21135279
[TBL] [Abstract][Full Text] [Related]
19. Acute lymphoblastic leukemia in infancy.
Silverman LB
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1070-3. PubMed ID: 17943956
[TBL] [Abstract][Full Text] [Related]
20. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
